United States · FDA National Drug Code directory
Benztropine Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-225_380cce0a-91d5-4c6e-80b0-e2b326264727
- Product NDC
- 50228-225
- Form
- TABLET
- Composition / generic term
- Benztropine Mesylate
- Labeler
- ScieGen Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241105
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZTROPINE MESYLATE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (50228-225-01) · 50228-225-01
- 1000 TABLET in 1 BOTTLE (50228-225-10) · 50228-225-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →